Market Place
Sourcing Support
Daiichi Sankyo Announces Late-Breaking Phase 1 Dose Expansion Data
17 Sep 2020 //
BIOSPACE
Zydus receives USFDA approval for Erlotinib Tablets
17 Apr 2020 //
BUSINESS-STANDARD
Cadila Healthcare gets final approval from USFDA for share price falls 3%
16 Apr 2020 //
MONEYCONTROL
Armas Pharmaceuticals Announces Launch of Oncology Generic Erlotinib
14 Nov 2019 //
PR NEWSWIRE
TAGRISSO, Only 1st-line Treatment for EGFR-Mutated Non-Small cell Lung Cancer
28 Sep 2019 //
BUSINESSWIRE
Meet the protein responsible for nearly $100B in cancer drug deals
17 Aug 2019 //
BIOPHARMADIVE
Tagrisso tops rival drugs on survival in first-line lung cancer
12 Aug 2019 //
PMLIVE
Sun Pharm`s generic Generic Erlotinib Receives Tentative Approval In US
24 Jul 2019 //
FDA
NICE shuts down AZ`s Tagrisso—and backs Pfizer rival Vizimpro instead
09 Jul 2019 //
FIERCE PHARMA
How a long-known biomarker backs BioNTech`s antibody for pancreatic cancer
20 Jun 2019 //
FIERCE PHARMA
Apotex`s Generic Erlotinib Receives Tentative Approval In US
03 Jun 2019 //
FDA
Accord Healthcare`s Generic Erlotinib Receives Tentative Approval in US
24 May 2019 //
FDA
Teva expands generic oncology pipeline with NSCLC treatment
20 May 2019 //
IN-PHARMATECHNOLOGIST
Mylan Expands Oncology Portfolio with Launch of Generic Tarceva® Tablets
11 May 2019 //
PR NEWSWIRE
With Alimta patent cliff looming, Lilly plots stronger foothold in NSCLC Cyramza
13 Mar 2019 //
ENDPTS
Betting on allosteric mutations driving cancer, Black Diamond raises $85M in fresh round
10 Jan 2019 //
ENDPTS
FDA Drafts Guidance on Oncology Companion Diagnostics
08 Dec 2018 //
RAPS
FDA approves Roche’s cobas EGFR blood test as a CDx for AZ’s Iressa
27 Aug 2018 //
FIERCE BIOTECH
Amneal Launches Budesonide Capsules
18 Jan 2018 //
PR NEWSWIRE
Clock starts ticking on AZ’s first-line lung cancer filing in US
19 Dec 2017 //
PMLIVE
Lilly’s Verzenio misses key survival goal in lung cancer
11 Oct 2017 //
PHARMA TIMES
Astellas Pharma To Discontinue ASP8273 Treatment Arm In Late-stage SOLAR Trial
10 May 2017 //
NASDAQ
Cancer drugs Tarceva and Sutent hold Ebola and dengue at bay in mice
28 Feb 2017 //
FIERCE BIOTECH
Genentech`s $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire
08 Feb 2017 //
BIOSPACE
Genprex Announces Positive Interim Data from PhII Clinical Trial of Oncoprex
06 Jan 2017 //
PR NEWSWIRE
Bioniz Appoints Paul Frohna as Senior VP of Clinical Development
20 Dec 2016 //
PR NEWSWIRE
AstraZeneca Pill Slashes Lung Cancer Progression in Study
07 Dec 2016 //
REUTERS
Pharma CEO Hunts New Trophy After Prostate Cancer Blockbuster
30 Nov 2016 //
BLOOMBERG
ICER calls for deep discounts to Opdivo, Keytruda, Tarceva, and others in NSCLC
01 Oct 2016 //
FIERCE PHARMA
EU nod for Avastin/Tarceva lung cancer combo
09 Jun 2016 //
PHARMATIMES
Drug makers pay $67m for misleading docs about cancer drug survival data
06 Jun 2016 //
STAT
FDA approves first blood test to detect gene mutation
02 Jun 2016 //
FDA
AstraZeneca keeps double-digit China growth on track in Q1
01 May 2016 //
FIERCE ASIA
Boehringer Ingelheim’s Giotrif wins new NSCLC licence in Europe
07 Apr 2016 //
PM LIVE
China NHFPC drug price pilot signals volume for cost-cuts formula
14 Mar 2016 //
FIERCE PHARMA ASIA
The pill that costs $9,000 in US sells for $70 in India
09 Feb 2016 //
ECONOMIC TIMES
SC agrees to hear Cipla`s plea against La Roche
28 Jan 2016 //
ET HEALTHWORLD
TARCEVA (erlotinib) - Use in Maintenance Treatment for Patients
18 Jan 2016 //
HEALTH CANADA
Roche, Glenmark settle patent dispute on Tarceva
02 Jan 2016 //
BUSINESS STANDARD
93 medicines recommended by CHMP in 2015
21 Dec 2015 //
PHARMATIMES
UK patients get early access to AZ`s lung cancer drug Tagrisso
09 Dec 2015 //
PM LIVE
Cipla weighs legal options after Delhi HC`s patent ruling
30 Nov 2015 //
ECONOMIC TIMES
Delhi HC upholds Roche`s patent claims on Tarceva against Cipla
28 Nov 2015 //
ECONOMIC TIMES
Merck CEO Blasts Company that Raised Drug Prices 5,000%
21 Nov 2015 //
FORTUNE
Express Scripts rolls out value-based pricing for cancer meds
19 Nov 2015 //
FIERCE PHARMA
Boehringer takes third-generation NSCLC drug into pivotal trials
03 Nov 2015 //
PM LIVE
U.S. cancer drug prices up to 3X higher than in Europe: Study
24 Sep 2015 //
FIERCE PHARMA
Exclusive: Americans overpaying hugely for cancer drugs - study
22 Sep 2015 //
REUTERS
Express Scripts seeks pay-for-performance deals for cancer drugs: report
28 May 2015 //
FIRSTWORD PHARMA
Drugmakers eye volume growth as China cuts prices by up to 67 percent
21 May 2015 //
REUTERS
12 cancer drugs may come under price control
05 May 2015 //
THE INDIAN EXPRESS
